Share on

Global Platelet Aggregation Devices Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Type, Application, End User and Region - Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 3402
Pages: 175
Formats: report pdf report excel report power bi report ppt

Global Platelet Aggregation Devices Market Size (2022 to 2027)

As per our report, the global platelet aggregation devices market size was valued at USD 284.86 million in 2022. This value is expected to grow at a CAGR of 21.2% and reach USD 744.97 million by 2027.

Platelet aggregation is the sequence of events leading to the formation of thrombus, which happens because of the structure of the clots in the blood. To stop this clotting traditional aggregometer works against the clotting on the principle of light transmission. This process is used for the diagnosis and the identification of defects in platelet functions. Light Transmission Aggregometer is the gold function to find this cause. To find the platelet defects, this method is used widely and remains the most useful technique. The platelet function analyzer is the result of the developments. The test performed by the PFA is automated and finds the functions of the platelet; this process is rapid and a high shear system. Hence the augmentation in the aggregometry technique improves the demand for these devices, helping in the growth of the market.

MARKET DRIVERS:

The most used downstream methods in the platelet aggregation devices market are VTE, ACS/MI, AF, etc. The overall study of the market covers the platelet aggregation devices market growth, which can help the stakeholders understand the growth opportunities in the market on the platelet aggregation devices and the contentious scenario. The analysis done by the global driven companies focuses on the data from primary and secondary sources. The collected information is useful for the investors to identify the opportunities and the scope in the market to invest in the right place. Those companies did the analysis also provide details about each segment in the global market.

The extensive growth in the population which is suffering from diseases is the result of the patient pool. Diseases like cardiovascular disease, bleeding disorders, and arthritis are the reason behind the increasing revenue of the hospitals. The factors which attract the large patient population in the hospitals are the offers given by the hospitals in the procedure of testing platelet aggregation, the high competitiveness, and the accessibility. These factors are propelling the growth of the market in the forecast period. Product propagation, product improvement, advertising, intensive promotion, and customized solutions are essential strategies that companies can adopt to gain profit which can be the advantage of the global platelet aggregation devices market in the forecast period.

MARKET RESTRAINTS:

Some factors that negatively impact market growth are the light transmission aggregometer process, which requires a large volume of patients, and time-consuming processes. Also, the analytical and pre-analytical variables affect the LTA results. These defects in the traditional method of aggregometry rupture the growth and advancement of aggregometry techniques adopted widely in the platelet aggregation devices market. 

COVID-19 Impact on the global platelet aggregation devices market:

Covid 19 has burdened the health care sector on a large scale; when covid 19 infected, the people and the government announced sudden lockdowns all over the world wide. There is no huge spread, but the infection had burdened the health care sector, mainly in the diagnostic sector, when time passed. Covid 19 severely affects the pulmonary system of the individual, making him/her difficult to breathe. Apart from that, it acts on the blood circulation; it fights with the antibodies in the blood and attacks them. Due to the infection in the blood, it loses the ability to clot and comes out of the body during cough in sputum. So, physicians must analyze the blood profile of patients. In such a case, platelet aggregation is performed; hence there is a huge demand for platelet aggregation devices.

Generally, in the method of platelet aggregation, the clotting tendency in platelets is identified, and any infection is noted with the help of light emission from the device on a film. But in modern diagnostics, many automated devices are being used for bulk sample testing. There is a huge demand for these kinds of machines or devices. Hence the pandemic has created a big market for these devices. But there has been sluggish growth in the manufacturing of these machines, owing to the increased raw material cost and supply chain disruptions, But the demand is being spurred on a positive base.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021 to 2027

Base Year

2021

Forecast Period

2022 to 2027

Segments Covered

By Product, Application, End-User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the global platelet aggregation devices market has been segmented and sub-segmented based on the product, application, end-user, and region.

Platelet Aggregation Devices Market - By Type:

  • Four-Channel
  • Dual-Channel
  • Eight-Channel

Based on the product, eight channel-based aggregation devices hold the largest share in the market. This can be attributed to the increasing automation and bulk testing feasibility of samples.

Platelet Aggregation Devices Market - By Applications:

  • Clinical Applications
  • Research Applications
  • Orthopedic Applications
  • Cardiovascular applications
  • Others

Based on application, the Clinical applications segment holds the largest market share due to the increased adoption of aggregator devices by healthcare professionals.

Platelet Aggregation Devices Market - By End Users:

  • Diagnostic Laboratories
  • Hospitals
  • Blood Banks
  • Institutional Laboratories

Based on end-user, the standalone hospitals are expected to hold the largest market share in the end-user segment due to increased platelet disorders and increasing use of platelet therapy for cancer patients.

Platelet Aggregation Devices Market - By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

North America, Asia Pacific, and Western Europe are expected to lead the platelet aggregation market during the forecast period. Western Europe and North America have upgraded healthcare infrastructures for early adoptions and product innovations. In terms of technology sectors and highly developed medical treatments. Also, the favorable policies for the growth of the healthcare services given by their regional governments are helpful. These are the reasons for the leading region, which are expected to drive the growth of the platelet aggregation devices market.

Countries like Germany, the US, UK, France, Canada, and Spain have the most reliable regional market. That Asia Pacific region is expected to reach the highest CAGR for Platelet Aggregation Devices Market in the coming future. South Korea, China, India, Australia, and Japan will play a key role in the Platelet Aggregation Devices Market growth. This region is expected the investments in global companies to fulfill the growing demand from the increasing population in recent years.

Eastern Europe, the Middle East, South America, Africa, and the rest of the world are likely to be the emerging markets in the forecast period for Platelet Aggregation Devices Market.

KEY MARKET PARTICIPANTS:

Some promising companies dominating the global platelet aggregation devices market profiled in the report are Helena Laboratories Corporation, Haemonetics Corporation, Siemens AG, Sysmex Corporation, Accriva Diagnostics, Sentinel CH. S.p.A, Bio/Data Corporation, Tem Group and Aggredyne, Inc.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: sales@marketdataforecast.com

Click for Request Sample